NCT03332290 (Dive-Hope) is a NA clinical trial of sport practice in Ptsd, sponsored by Marion Trousselard.

Who is sponsoring NCT03332290?

NCT03332290 is sponsored by Marion Trousselard.

What drugs are being tested in NCT03332290?

Interventions in NCT03332290: sport practice.

Is NCT03332290 still recruiting?

NCT03332290 is currently completed. Last updated 27 February 2019.

Last reviewed 2019-02-27 · How we verify

NCT03332290: Dive-Hope

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diving for Post Traumatic Stress Disorder (PTSD)

Completed NA Last updated 27 February 2019

What this trial tests

NA trial testing sport practice in Ptsd in 36 participants. Completed in 26 February 2019.

Timeline

10 October 2017

Primary endpoint
30 December 2017

26 February 2019

Quick facts

Lead sponsor	Marion Trousselard
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	36
Start date	10 October 2017
Primary completion	30 December 2017
Estimated completion	26 February 2019
Sites	1 location across France

Drugs / interventions tested

sport practice

Conditions studied

Ptsd — all drugs for Ptsd →

Sponsor

Marion Trousselard — full company profile →

Who can join

18 and older, any sex, with Ptsd. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

within the components of Scuba diving there are similarities with meditation and mindfulness techniques. PTSD and emotion dysregulation are known to be involved by meditation training This study evaluates the benefits of scuba diving on quality of life and mindful functioning comparing the benefits of diving training using a clinical trial protocol

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparing meditative scuba diving versus multisport activities to improve post-traumatic stress disorder symptoms: a pilot, randomized controlled clinical trial.
Gibert L, Coulange M, Reynier JC, Le Quiniat F, et al · · 2022 · cited 5× · PMID 35145610 · DOI 10.1080/20008198.2022.2031590

Verify or expand the search:

Other recruiting trials for Ptsd

Currently open trials in the same condition.

NCT06037785 — Self-Management Interventions After an ICD Shock · NA · recruiting
NCT06718387 — Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence · NA · recruiting
NCT05228964 — Focused Ultrasound Amygdala Neuromodulation · NA · active not recruiting
NCT05147948 — iACT for PTSD and Chronic Pain · NA · recruiting
NCT04582695 — Early Intervention Following Sexual Assault · NA · active not recruiting

Other Marion Trousselard trials

Trials by the same sponsor.

NCT03227562 — Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety? · Phase 3 · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03332290 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marion Trousselard
Last refreshed: 27 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03332290.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing